Literature DB >> 32535047

Multiple domains in the 50 kDa form of E4F1 regulate promoter-specific repression and E1A trans-activation.

Robert J Rooney1.   

Abstract

The 50 kDa N-terminal product of the cellular transcription factor E4F1 (p50E4F1) mediates E1A289R trans-activation of the adenovirus E4 gene, and suppresses E1A-mediated transformation by sensitizing cells to cell death. This report shows that while both E1A289R and E1A243R stimulate p50E4F1 DNA binding activity, E1A289R trans-activation, as measured using GAL-p50E4F1 fusion proteins, involves a p50E4F1 transcription regulatory (TR) region that must be promoter-bound and is dependent upon E1A CR3, CR1 and N-terminal domains. Trans-activation is promoter-specific, as GAL-p50E4F1 did not stimulate commonly used artificial promoters and was strongly repressive when competing against GAL-VP16. p50E4F1 and E1A289R stably associate in vivo using the p50E4F1 TR region and E1A CR3, although their association in vitro is indirect and paradoxically disrupted by MAP kinase phosphorylation of E1A289R, which stimulates E4 trans-activation in vivo. Multiple cellular proteins, including TBP, bind the p50E4F1 TR region in vitro. The mechanistic implications for p50E4F1 function are discussed.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenovirus E1A oncogene; E4F1 transcription factor; Trans-activation; Transcriptional repressor

Mesh:

Substances:

Year:  2020        PMID: 32535047      PMCID: PMC7394487          DOI: 10.1016/j.gene.2020.144882

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  144 in total

1.  E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation.

Authors:  Laurent Le Cam; Laëtitia K Linares; Conception Paul; Eric Julien; Matthieu Lacroix; Elodie Hatchi; Robinson Triboulet; Guillaume Bossis; Ayelet Shmueli; Manuel S Rodriguez; Olivier Coux; Claude Sardet
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

2.  A protein kinase is present in a complex with adenovirus E1A proteins.

Authors:  T Kleinberger; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  trans-dominant mutants of E1A provide genetic evidence that the zinc finger of the trans-activating domain binds a transcription factor.

Authors:  L C Webster; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

4.  Adenovirus E1A is associated with a serine/threonine protein kinase.

Authors:  C H Herrmann; L K Su; E Harlow
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  DNA-binding activity of the adenovirus-induced E4F transcription factor is regulated by phosphorylation.

Authors:  P Raychaudhuri; S Bagchi; J R Nevins
Journal:  Genes Dev       Date:  1989-05       Impact factor: 11.361

6.  Adenovirus E1A proteins interact with the cellular YY1 transcription factor.

Authors:  B A Lewis; G Tullis; E Seto; N Horikoshi; R Weinmann; T Shenk
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

8.  Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis.

Authors:  Yong Liao; Mien-Chie Hung
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  Multiple roles for acetylation in the interaction of p300 HAT with ATF-2.

Authors:  Balasubramanyam Karanam; Ling Wang; Dongxia Wang; Xin Liu; Ronen Marmorstein; Robert Cotter; Philip A Cole
Journal:  Biochemistry       Date:  2007-06-23       Impact factor: 3.162

10.  Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7-HMGA2-Cyclin A2 Pathway.

Authors:  Yixuan Li; Lirong Peng; Edward Seto
Journal:  Mol Cell Biol       Date:  2015-08-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.